These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4253800)

  • 21. Azalomycin F, an antibiotic against fungi and Trichomonas.
    Arai M
    Arzneimittelforschung; 1968 Nov; 18(11):1396-9. PubMed ID: 5756065
    [No Abstract]   [Full Text] [Related]  

  • 22. [The production of antifungal metabolites by Pseudomonas chlororaphis grown on different nutrient sources].
    Shtark OIu; Shaposhnikov AI; Kravchenko LV
    Mikrobiologiia; 2003; 72(5):645-50. PubMed ID: 14679903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.
    Bennett JE; Powers J; Walsh T; Viscoli C; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Kauffman C; Lee J; Pappas P; Rex J; Verweij P
    Clin Infect Dis; 2003 Apr; 36(Suppl 3):S117-22. PubMed ID: 12679895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic fate of the anti-inflammatory agent alpha-(4-(1-oxo-2-isoindolinyl)-phenyl)-propionic acid (K 4277) in the rhesus monkey.
    Chasseaud LF; Fry BJ; Valzelli G; Tosolini GP
    Arzneimittelforschung; 1974 Oct; 24(10):1606-9. PubMed ID: 4479769
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimising antifungal therapy for individual patients.
    Hope WW; Denning DW
    Intern Med J; 2004 Apr; 34(4):147-9. PubMed ID: 15086692
    [No Abstract]   [Full Text] [Related]  

  • 26. Bromfenac for analgesia.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):93-4. PubMed ID: 9379997
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fungal infections of the eye--current antifungal agents].
    Samsel A; Meszaros J
    Klin Oczna; 2002; 104(2):155-60. PubMed ID: 12174460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical experience with the systemic administration of clotrimazol. Pharmacokinetics, action, tolerance].
    Weuta H
    Arzneimittelforschung; 1974 Apr; 24(4):540-5. PubMed ID: 4408040
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experiences with new antifungal agents: 2-aminotridecan-undecylenate (VUFB 7477) and 2-aminotridecan-2-chloro-4-nitrophenolate (VUFB 8115)].
    Klĩma J
    Cesk Dermatol; 1972 Dec; 47(6):252-5. PubMed ID: 4576921
    [No Abstract]   [Full Text] [Related]  

  • 30. Micafungin.
    Carver PL
    Ann Pharmacother; 2004 Oct; 38(10):1707-21. PubMed ID: 15340133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metabolism and blood level of a new analgesic and antiphlogistic 2-(2-methoxy-ethoxy)-5-acetaminoacetophenone (Ap 752). 2. Research in humans].
    Pelzer H; Müller E
    Arzneimittelforschung; 1968 Nov; 18(11):1400-4. PubMed ID: 5755903
    [No Abstract]   [Full Text] [Related]  

  • 32. Preventative use of antifungal drugs in patients treated for cancer.
    de Pauw B
    J Antimicrob Chemother; 2004 Feb; 53(2):130-2. PubMed ID: 14729743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, excretion and metabolism of a new analgesic and anti-inflammatory drug K 4277 in rats, guinea pigs, rabbits and dogs.
    Goldaniga GC; Pianezzola E; Valzelli G
    Arzneimittelforschung; 1974 Oct; 24(10):1603-6. PubMed ID: 4479768
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: concepts and considerations.
    Lipsett PA
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S193-9. PubMed ID: 15546117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Considerations in clinical trials of combination antifungal therapy.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S228-35. PubMed ID: 15546123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Issues in clinical trials of prophylaxis of fungal infections.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S211-7. PubMed ID: 15546120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal guidelines.
    Shaw PJ
    Intern Med J; 2004; 34(9-10):585-6, author reply 586-7. PubMed ID: 15482279
    [No Abstract]   [Full Text] [Related]  

  • 39. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
    Singh N
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S200-6. PubMed ID: 15546118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of provoked vestibulodynia: a critical review.
    Landry T; Bergeron S; Dupuis MJ; Desrochers G
    Clin J Pain; 2008 Feb; 24(2):155-71. PubMed ID: 18209522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.